Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
Recent client coverage highlights
Some of our favourite coverage from Q1 2022
Kazia Therapeutics advances human trials for lead cancer drugs during December quarter.
Click here to read more
CSO Dr Daniel Tillett Talks To Proactive About Recent Kidney Cancer Results.
Click here to watch
A good night's sleep may be down to bacteria. A Queensland company is pursuing the idea that what’s in your stomach may be causing insomnia.
Click here to read more
John Kelly spoke with Jack Crnjanin on Joy 94.9 Radio’s Well Well Well podcast about the Atomo HIV self-test and the health and awareness benefits to come from the TGA’s recent amendments to rules.
Click here to listen to the podcast.
Martin Filz recently spoke with Proactive Investor’s Andrew Scott about Pureprofile and its recent half yearly earnings performance.
Click here to watch
Oventus Medical, incoming CEO, John Cox, speaks with Andrew Scott from Proactive Investors about the innovations and competitive advantage of Oventus’ sleep apnea therapeutic oral device.
Click here to watch
